<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04557553</url>
  </required_header>
  <id_info>
    <org_study_id>SUNT001</org_study_id>
    <nct_id>NCT04557553</nct_id>
  </id_info>
  <brief_title>Effects of Lagenbone on Bone Mineral Density</brief_title>
  <official_title>Effects of Lagenbone on Improvements in Bone Mineral Density - A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southern California University of Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sun Ten Pharmaceutical Co Ltd.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Southern California University of Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the effects of the herbal supplement Lagenbone on Bone Mineral Density&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To study the effects of the herbal supplement Lagenbone on Bone Mineral Density. Lagenbone is&#xD;
      a supplement based on the Chinese Herbal formula Gui Lu Er Xian Jiao.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 15, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dual-energy x-ray absorptiometry (DXA)DEXA Scan</measure>
    <time_frame>15 months</time_frame>
    <description>Dual-energy x-ray absorptiometry (DXA) or bone densitometry or Bone Density Scan</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Short Osteoporosis Quality of Life Questionnaire (ECOS16)</measure>
    <time_frame>15 months</time_frame>
    <description>Short Osteoporosis Quality of Life Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>36-item Short form survey (SF36)</measure>
    <time_frame>15 months</time_frame>
    <description>36-item Short form survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Osteoporotic Quality of Life Questionnaire (OQLQ10)</measure>
    <time_frame>15 months</time_frame>
    <description>Osteoporotic Quality of Life Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>Lagenbone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lagenbone 500mg capsules, 8 capsules by mouth every day for 12 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lagenbone</intervention_name>
    <description>Traditional Chinese medicine herbal formula</description>
    <arm_group_label>Lagenbone</arm_group_label>
    <other_name>Gui Lu Er Xian Jiao</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Confirmed diagnosis of osteoporosis&#xD;
&#xD;
          -  Able to read and understand English&#xD;
&#xD;
          -  Willing to receive routine DEXA scans and comply with supplement schedule&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant, lactating, or having gestational diabetes&#xD;
&#xD;
          -  Diagnosed with comorbid conditions that they are taking medication for e.g. Acid&#xD;
             reflux, Hashimoto's/Grave's Disease, Endometriosis, prostate, breast, uterine cancer,&#xD;
             kidney disease, fibroids, psychological disorders&#xD;
&#xD;
          -  Use of any medication known to interfere with bone mineral density&#xD;
&#xD;
          -  Are taking any new medications/supplements/treatments/therapeutic exercise within the&#xD;
             last two months for osteoporosis or bone density&#xD;
&#xD;
          -  Involved in health-related litigation, claims&#xD;
&#xD;
          -  Missing baseline visits&#xD;
&#xD;
          -  Vegan or vegetarian&#xD;
&#xD;
          -  Diagnosed with Alzheimer's or demonstrating onset of dementia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prasad S Vinjamury, DACM, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southern California University of Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Southern California University of Health Sciences</name>
      <address>
        <city>Whittier</city>
        <state>California</state>
        <zip>90604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 30, 2020</study_first_submitted>
  <study_first_submitted_qc>September 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2020</study_first_posted>
  <last_update_submitted>September 2, 2021</last_update_submitted>
  <last_update_submitted_qc>September 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southern California University of Health Sciences</investigator_affiliation>
    <investigator_full_name>Sivarama Vinjamury</investigator_full_name>
    <investigator_title>Professor, Research Director</investigator_title>
  </responsible_party>
  <keyword>chinese medicine</keyword>
  <keyword>herbal medicine</keyword>
  <keyword>osteoporosis</keyword>
  <keyword>bone mineral density</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

